APA (7th ed.) Citation

Muller, S. A., & Oerlemans, M. I. (2023). Implementing clinical pathways to enable early diagnosis and treatment of wild‐type transthyretin amyloid cardiomyopathy. European Journal of Heart Failure, 25(6), 854. https://doi.org/10.1002/ejhf.2890

Chicago Style (17th ed.) Citation

Muller, Steven A., and Marish I.F.J Oerlemans. "Implementing Clinical Pathways to Enable Early Diagnosis and Treatment of Wild‐type Transthyretin Amyloid Cardiomyopathy." European Journal of Heart Failure 25, no. 6 (2023): 854. https://doi.org/10.1002/ejhf.2890.

MLA (9th ed.) Citation

Muller, Steven A., and Marish I.F.J Oerlemans. "Implementing Clinical Pathways to Enable Early Diagnosis and Treatment of Wild‐type Transthyretin Amyloid Cardiomyopathy." European Journal of Heart Failure, vol. 25, no. 6, 2023, p. 854, https://doi.org/10.1002/ejhf.2890.